This web only provides the extract of this article. If you want to read the figures and tables, please reference the PDF full text on Blackwell Synergy. Thank you.
- Original Article -
Relationship between testosterone and indexes indicating
endothelial function in male coronary heart disease patients
Lu Fu, Qian-Ping Gao, Jing-Xia Shen
Cardiovascular Department, the First Affiliated Hospital of Harbin Medical University, Harbin 150001, China
Abstract
Aim: To investigate the relationship between androgen level and the indexes indicating endothelial function in male
patients with coronary heart disease (CHD). Methods:
We registered the following data for 106 50_70-year-old men:
age, weight, blood lipid, including total cholesterol, low density lipoprotein cholesterol, high density lipoprotein
cholesterol and triglyceride, whether a smoker, sugar levels, blood pressure, free testosterone (FT), vascular cell adhesion
molecule-1 (VCAM-1) and the intima-media thickness (IMT) of common carotid artery, common carotid diameter,
maximum velocity in systolic phase, minimum velocity in diastolic phase and resistent index. Among the 106 men, 51
were patients with CHD. The relationships between FT level, VCAM-1 concentration and IMT were examined,
respectively, using a stepwise linear regression technique among all the 106 men.
Results: There was no statistical difference in terms of age, blood pressure, whether a smoker, sugar levels, HDL-C, minimum velocity in diastolic
phase, resistent index between male CHD patients and controls; whereas results for weight, total cholesterol, low
density lipoprotein cholesterol, triglyceride, VCAM-1 and IMT of male CHD patients were higher than those of
controls; FT level and maximum velocity in systolic phase were lower. It was found that among all the objects, FT
level was inversely correlated with IMT and VCAM-1
concentration. Conclusion: FT level was inversely correlated
with VCAM-1 concentration and IMT which are indicators of endothelial
function. (Asian J Androl 2008 Mar; 10: 214_218)
Keywords: testosterone; coronary heart disease; endothelial function
Correspondence to: Dr Qian-Ping Gao, the First Affiliated Hospital of Harbin Medical University, No. 23 Youzheng Street, Nangang
District, Harbin 150001, China.
Tel: +86-451-8952-2198 Fax: +86-451-5367-0428
E-mail: gaoqianping@sohu.com
Received 2007-03-17 Accepted 2007-08-20
DOI: 10.1111/j.1745-7262.2008.00335.x
1 Introduction
Coronary heart disease (CHD) is associated with
several factors, including cigarette smoking, diabetes,
hypertension and elevated serum lipids. Some data
shows that men with proven coronary atherosclerosis have lower levels of
endogenous androgens than healthy controls [1]. According to Channer and Jones [2] and Dobrzycki
et al. [3], the decrease in genital function might play an important role during the progression of atherosclerosis in men. However,
the mechanism is thus far unknown. Damage to endothelial function is acknowledged to be the initial step in the
formation of atherosclerotic lesions, so we investigate the relationship between androgen level and some indexes
indicating endothelial function.
2 Materials and methods
2.1 Subjects
Fifty-one male patients aging from 56 to 76 years
were recruited to cardiovascular department of the First
Affiliated Hospital of Harbin Medical University. Among
these patients, 11 were diagnosed with acute
myocardial infarction (AMI), defined by the World Health
Organization (WHO) criteria as a combination of typical
symptoms, serial electrocardiogram (ECG) changes and
elevation in cardiac enzymes; 12 patients were diagnosed
with old myocardial infarction with certain history of
AMI; 19 patients were diagnosed with angina pectoris
with typical symptoms, ECG and Holter; and in nine
patients coronary stenosis was discovered through
coronary angiography, without any symptoms. Patients were
excluded if they had any of the following diseases:
diabetes mellitus, cerebral vascular disease, chronic diseases,
dysfunction of liver and kidney and peripheral vascular
disease. We enlisted 55 male controls aging from 55 to
74 years. Controls had no history of CHD attack or
positive ECG changes, including 18 healthy volunteers
from the community, 17 volunteers from the Center of
Medical Examination of the First Affiliated Hospital of
Harbin Medical University (Harbin, China), 20 people with
normal coronary arteries as determined by coronary
angiography. Men were excluded if they had any of the
following diseases: diabetes mellitus, cerebral vascular
disease, chronic diseases, dysfunction of liver and kidney,
or peripheral vascular disease.
2.2 Reagents
A vascular cell adhesion molecule-1 (VCAM-1) enzyme-immunity association kit was obtained from
Senxiong Science and Technology in Shanghai, China; a
free testosterone (FT) enzyme-immunity association kit
DSL-10-49100 was obtained from Diagnostic Systems Laboratories (Webster, TX, USA).
2.3 Apparatus
An echocardiograph (VIVID FIVE US GE, Fairfield,
CA, USA) was used.
2.4 Procedures
2.4.1 Blood samples collection
The blood samples were collected in the fasting state
on the next morning after admission and were separated
and stored at _70ºC until assayed. Several blood samples
of each patient were sent to clinical laboratories for assay
of cholesterol (TC), low density lipoprotein cholesterol
(LDL-C), high density lipoprotein cholesterol
(HDL-C), triglyceride (TG) and sugar levels. The rest of the
samples were tested for VCAM-1 and FT levels in the
central lab at the same time. Each sample was separated
into three holes in the platform and the average of the
three values was taken as laboratory data.
2.4.2 Ultrasound studies
The studies were performed on fasting patients
between 7: 30 am and 9: 00 am. To minimize external stimuli,
all studies were carried out in a silent clinical research
laboratory room. Blood pressure was measured twice
during the ultrasound examination. All studies were
performed following a predetermined, standardized
scanning protocol for the right and left carotid arteries.
Subjects were examined in a supine position, with head turned
to the opposite side of the carotid artery under
examination. The proximal part of the carotid bulb was identified,
and the segment of the common carotid artery 1_2 cm
proximal to the bulb was scanned. Two end-diastolic
frames of the best image quality were selected and
analyzed for maximum intima media thickness (IMT), and
the average reading from these two frames was
calculated for both the right and left carotid arteries.
Common carotid diameter (D), maximum velocity in systolic
phase (Vsmax), minimum velocity in diastolic phase
(Vdmin) and resistent index (RI) were also tested.
2.5 Statistical analysis
Results are expressed as mean ± SD. Comparisons
between the groups were conducted by independent samples
t-test and χ2-test. Multivariate analyses were
done through a stepwise linear regression analysis of all
106 men. The following explanatory variables were
included in the analysis: age, weight, TC, LDL-C, HDL-C,
TG, sugar, systolic blood pressure (SBP), diastolic blood
pressure (DBP), whether a smoker and FT. All
statistical analyses were performed using the SPSS
version 13.0 statistical analysis system (SPSS, Chicago, IL, USA).
P < 0.05 was taken as significant.
3 Results
Characteristics of the study groups are shown in
Table 1. The association between VCAM-1 and risk
factors of the 106 men are shown in Table 2. In the stepwise
multivariate regression held across analyses of the 106
men, the independent explanatory variables for VCAM-1
include FT (P < 0.01), TG
(P < 0.01), smoking
(P < 0.01) and weight
(P < 0.05). There is no correlation between
VCAM-1 and age, TC, LDL-C, HDL-C, sugar, SBP and DBP.
Association between IMT and risk factors of the 106
men are shown in Table 3.
In the stepwise multivariate regression held across
analyses of the 106 men, the independent explanatory
variables for carotid IMT include FT
(P < 0.01), smoking
(P < 0.01), age
(P < 0.01) and TC
(P < 0.05). There is no correlation between IMT and weight, TG, HDL-C,
LDL-C, sugar, SBP or DBP.
4 Discussion
The initial steps in the formation of atherosclerotic
lesion involve the adherence of circulation monocytes to
dysfunctional endothelium and transmigration into the
arterial intima, so the expression of vascular cell
adhesion molecule-1 (VCAM-1) might be a key regulatory point
in controlling the atherosclerotic process.
VCAM-1 is produced by endothelial cells, tumor cells, and so on, and its
expression increases during inflammation and tumor. The
mechanism of atherosclerosis includes the theory of
inflammation. When endothelial cells are activated by
malignant stimulation, virus and inflammation factors,
such as tumor necrosis factor-α (TNF-α), interleukin-1
(IL-1) and interleukin-2 (IL-2), the expression of
VCAM-1 increases. Had androgen inhibited the expression of
endothelial adhesion molecules, it would have relieved
atherosclerotic lesions. It was revealed that testosterone
levels of male patients with CHD were lower than those
of controls [1, 4]. It is well-known that CHD is
associated with several factors, such as cigarette smoking,
diabetes, hypertension and elevated serum lipids. Blood
lipids, diabetes and hypertention are usually higher in CHD
patients than in healthy people. During the experiment,
the relationship between FT level and VCAM-1
concentration was analyzed, with the latter as the target.
Multivariate analyses showed that FT was inversely
correlated with VCAM-1 concentration. In
vitro experiments revealed that androgen restrained endothelial cells from
excreting VCAM-1 by preventing nuclear factor kappaB
from activation [5]. Therefore, proper androgen levels
might inhibit the elevation of VCAM-1 expression. Proper
testosterone levels might improve endothelial function.
Carotid IMT is a widely accepted noninvasive
measure of preclinical atherosclerosis and an independent
predictor of future adverse cardiovascular and
cerebrovascular events. A limited number of previous
observations have suggested that carotid IMT is inversely
associated with serum T levels in very elderly men [6], in
men with type II diabetes [7], and in obese men [8].
Makinen et al. [9] reported that middle-aged men with
symptoms of andropause, together with absolute or
compensated testosterone deficiency, show increased carotid
IMT. Therefore, hypotestosteronemia might accelerate
the development of atherosclerosis and increase the risk
of CHD. A recent study indicated the serum T
concentration was inversely associated with the progression of
carotid atherosclerosis in elderly men [10]. Our data
showed the FT level of male patients with CHD was lower than that of controls, which corresponds with
previous research [4]. The findings demonstrate an inverse
association between serum FT and IMT; therefore, it is
speculated that endogenous testosterone levels might play
a protective role in the development of atherosclerosis.
Hak et al. [11] demonstrate in a large population-based
study that serum T levels inversely and independently
correlate with the presence of aortic calcified plaques
and the progression of aortic atherosclerosis.
Experimental male animal studies show that androgens reduce
diet-induced and injury-induced atherosclerosis [12, 13].
The current evidence suggests that normal androgen levels
might protect aging men from the development of atherosclerosis. The possible underlying mechanisms
might include the anti-inflammatory effects of normal
physiological levels of sex hormones, regulation of
apoptosis, and promotion of smooth muscle cell stability.
Endothelium is not only a barrier to blood stream,
but also the biggest endocrine organ in the body. With
its complex function, endothelium might be influenced
by many factors, such as hypertention, diabetes,
cigarette smoking, and so on. Several indexes are applied to
reflect the endothelial function. The present experiment
has shown that FT is inversely correlated with VCAM-1
and IMT, which are taken as some of the indicators of
endothelial function. Further investigations are required
to explore the relationship between androgen and
endoth-elial function.
As men aging, their testosterone levels decline, and
some changes in body and mind occur in accordance with decreases in androgen levels, such as increases in
fat tissues, decreases in muscle, lipids changes, anaemia
and fatigue. What was once called andropause is now
referred to as partial androgen deficiency of the aging
male. Low serum sex hormone binding globulin, low
total testosterone and clinical androgen deficiency are
associated with increased risk of developing metabolic
syndrome over time. Therefore, they might provide early
warning signs for cardiovascular risk and an
opportunity for early intervention in men [14, 15]. Approved
low-dose supplemental testosterone treatment in men with
chronic stable angina reduces exercise-induced
myocardial ischemia [16]. These issues bear on the potential
use of testosterone replacement in aging men.
In fact, testosterone has been used as a compound
for treatment of testosterone deficiency for almost
70 years. Researchers have been trying to develop new
testosterone preparations or testosterone analogs because
the traditional injective testosterone ester cannot
maintain stable testosterone levels [17_19]. At present, there
are several big volume multi-center clinical observations
concerning testosterone supplement therapy being
carried out worldwide.
References
1 English KM, Mandour O, Steeds RP, Diver MJ, Jones TH,
Channer KS. Men with coronary artery disease have lower
levels of androgens than men with normal coronary angiograms.
Eur Heart J 2000; 21: 890_4.
2 Channer KS, Jones TH. Cardiovascular effects of testosterone:
implications of the "male menopause"? Heart 2003; 89: 121_2.
3 Dobrzycki S, Serwatka W, Nadlewski S, Korecki J, Jackowski
R, Paruk J, et al. An assessment of correlations between
endogenous sex hormone levels and the extensiveness of
coronary heart disease and the ejection fraction of the left ventricle
in males. J Med Invest 2003; 50: 162_9.
4 Kajinami K, Takeda K, Takekoshi N, Matsui S, Tsugawa H,
Kanemitsu S, et al. Imbalance of sex hormone levels in men
with coronary artery disease. Coron Artery Dis 2004; 15:
199_203.
5 Hatakeyama H, Nishizawa M, Nakagawa A, Nakano S, Kigoshi
T, Uchida K. Testosterone inhibits tumor necrosis
factor-alpha-induced vascular cell adhesion molecule-1 expression in
human aortic endothelial cells. FEBS Lett 2002; 530: 129_32.
6 van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts
SW, Grobbee DE. Endogenous hormones and carotid
atherosclerosis in elderly men. Am J Epidemiol 2003; 157: 25_31.
7 Fukui M, Kitagawa Y, Nakamura N, Kadono M, Mogami S,
Hirata C, et al. Association between serum testosterone
concentration and carotid atherosclerosis in men with type 2
diabetes. Diabetes Care 2003; 26: 1929_31.
8 De Pergola G, Pannacciulli N, Ciccone M, Tartagni M, Rizzon
P, Giorgino R. Free testosterone plasma levels are
negatively associated with the intima-media thickness of the
common carotid artery in overweight and obese glucose-tolerant
young adult men. Int J Obes Relat Metab Disord 2003; 27:
803_7.
9 Mäkinen J, Järvisalo MJ, Pöllänen P, Perheentupa A, Irjala K,
Koskenvuo M, et al. Increased carotid atherosclerosisin
andropausal middle-aged men. J Am Coll Cardiol 2005; 45:
1603_8.
10 Muller M, van den Beld AW, Bots ML, Grobbee DE,
Lamberts SW, van der Schouw YT. Endogenous sex hormones and
progression of carotid atherosclerosis in elderly men.
Circulation 2004, 109: 2074_9.
11 Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A,
Pols HA. Low levels of endogenous androgens increase the
risk of atherosclerosis in elderly men: the Rotterdam study. J
Clin Endocrinol Metab 2002; 87: 3632_9.
12 Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS.
Testosterone as a protective factor against
atherosclerosisimmunomodulation and influence upon plaque development
and stability. J Endocrinol 2003;178: 373_80.
13 Nathan L, Shi W, Dinh H, Mukherjee TK, Wang X, Lusis AJ,
et al. Testosterone inhibits early atherogenesis by conversion
to estradiol: critical role of aromatase. Proc Natl Acad Sci U S
A 2001; 98: 3589_93.
14 Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ,
McKinlay JB. Low sex hormone-binding globulin, total
testosterone, and symptomatic androgen deficiency are
associated with development of the metabolic syndrome in
nonobese men. J Clin Endocrinol Metab 2006; 91: 843_50.
15 Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR,
Baltimore Longitudinal Study of Aging. Longitudinal effects
of aging on serum total and free testosterone levels in healthy
men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol
Metab 2001; 86: 724_31.
16 English KM, Steeds RP, Jones TH, Diver MJ, Channer KS.
Low-dose transdermal testosterone therapy improves angina
threshold in men with chronic stable angina: a randomized,
double-blind, placebo-controlled study. Circulation 2000; 102:
1906_11.
17 Liu WJ, Xin ZC, Xin H, Yuan YM, Tian L, Guo YL. Effects
of icariin on erectile function and expression of nitric oxide
synthase isoforms in castrated rats. Asian J Androl 2005; 7:
381_8.
18 Zhang ZB, Yang QT. The testosterone mimetic properties of
icariin. Asian J Androl 2006; 8: 601_5.
19 Saad F, Kamischke A, Yassin A, Zitzmann M, Schubert M,
Jochenhel F, et al. More than eight years' hands-on experience
with the novel long-acting parenteral testosterone undecanoate.
Asian J Androl 2007; 9: 291_7.
|